Please ensure Javascript is enabled for purposes of website accessibility
Главная > Продукты > Антитела > Биосимиляры

Anti-Human BCMA/TNFRSF17 Reference Antibody (Ispectamab, RUO) (HX959076)

Anti-Human BCMA/TNFRSF17 Reference Antibody (Ispectamab, RUO)
Anti-Human BCMA/TNFRSF17 Reference Antibody (Ispectamab, RUO)
Anti-Human BCMA/TNFRSF17 Reference Antibody (Ispectamab, RUO)
Anti-Human BCMA/TNFRSF17 Reference Antibody (Ispectamab, RUO)
Anti-Human BCMA/TNFRSF17 Reference Antibody (Ispectamab, RUO)
Anti-Human BCMA/TNFRSF17 Reference Antibody (Ispectamab, RUO)
Цена(USD):
Спецификация:
  • 100ug
  • 1mg
  • 5mg
  • 10mg
  • 25mg
  • 50mg
  • 100mg
Количество:
Свяжитесь с нами
  • Обзор

  • Изображения

  • Ссылки

  • Даташит

  • SDS

Обзор
Каталожный номерHX959076
Описание
Ispectamab (HX959076) is a research-grade recombinant antibody targeting CD269. Produced in mammalian cells with native-like glycosylation.
Highlights
  • ●Research Grade — For PK/PD studies, assay development, and ADA research.
  • ●Native Glycosylation — Mammalian expression ensures native-like patterns.
Реактивность видовHuman
ПримененияELISA, Bioactivity: FCM, Functional assay, Research in vivo
Хозяинский видHuman
КлоональностьMonoclonal
ИзотипIgG1-kappa
Проверенные приложения WB
Цель B-cell maturation protein, BCM, BCMA, CD269, TNFRSF17, Tumor necrosis factor receptor superfamily member 17
Уровень эндотоксинов < 10 EU/mg
Чистота >95% as determined by SDS-PAGE.
Очистка Protein A/G purified from cell culture supernatant.
Номер доступа Q02223
Форма Liquid
Буфер хранения 0.01M PBS pH 7.4.

Пожалуйста, обратитесь к конкретной информации о буфере в печатной версии даташита или в индивидуальном сертификате качества (COA) для партии.

Устойчивость и хранение Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Альтернативные названияBMS-986352, CC-99712, CC99712, CC99712, SP8919, 2413386-21-5
Фон

Tumor necrosis factor receptor superfamily member 17 (CD269/BCMA) is a ~20 kDa protein. Receptor for TNFSF13B/BLyS/BAFF and TNFSF13/APRIL. Promotes B-cell survival and plays a role in the regulation of humoral immunity. Activates NF-kappa-B and JNK. CD269 is the therapeutic target of teclistamab (Tecvayli).

Примечание For research use only. Not suitable for clinical or therapeutic use.
Изображения
  • Anti-Human BCMA/TNFRSF17 Reference Antibody (Ispectamab, RUO)

    Western blot

    Western blot analysis was performed using anti-CD269 monoclonal antibody at 1ug/mL on various samples.
    Lane 1: recombinant human CD269 (Catalog No: HX959012)
    Lane 2: negative control

  • Anti-Human BCMA/TNFRSF17 Reference Antibody (Ispectamab, RUO)

    SDS-PAGE

    SDS-PAGE for Research Grade Ispectamab.

  • Anti-Human BCMA/TNFRSF17 Reference Antibody (Ispectamab, RUO)

    Bioactivity

    Detects recombinant human CD269/TNFRSF17/BCMA (Catalog No: HX959012) in indirect ELISA

Ссылки
Formula
Mass (g) = Concentration (mol/L) × Volume (L) × MW (g/mol)
Enter any 2 of Mass, Concentration, Volume + Molecular Weight to solve for the unknown.
Mass
=
Concentration
×
Volume
Molecular Weight *
g/mol
Formula
C₁ × V₁ = C₂ × V₂
Enter any 3 of the 4 values to solve for the unknown.
Stock Solution
C₁ (Stock Conc.)
×
V₁ (Stock Vol.)
=
Working Solution
C₂ (Working Conc.)
×
V₂ (Working Vol.)
Рекомендация

Свяжитесь с нами для индивидуальных предложений, оптовых запросов и других вопросов.

Почта: [email protected]

Список дистрибьюторов